About TransMedics Group, Inc. - Common Stock (TMDX)
Transmedics Group Inc is a biotechnology company focused on revolutionizing the organ transplant process through innovative medical technologies. They have developed a unique organ preservation and transportation system that optimizes the viability of donor organs, specifically targeting hearts, lungs, and livers. By employing advanced perfusion technology, Transmedics aims to improve patient outcomes and increase the availability of transplantable organs, ultimately addressing the critical shortages faced in the transplant community. Their commitment to enhancing the transplant experience positions them as a leader in the field of organ transplantation. Read More
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the “Class Period”), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) and reminds investors of the April 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
RADNOR, PA - April 14, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options
RADNOR, PA - April 12, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
PHILADELPHIA, April 11, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Transmedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX). The lawsuit has been filed on behalf of purchasers of TransMedics securities between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).
RADNOR, PA - April 10, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In TransMedics To Contact Him Directly To Discuss Their Options
RADNOR, PA - April 8, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.
